Who We Are
TSRL is a private, preclinical accelerator based in Ann Arbor, Michigan, focused on translating early-stage infectious disease therapeutics into viable clinical assets. We are a team of pharma industry veterans with deep drug development expertise, ranging from discovery and preclinical development to clinical, regulatory, and IP strategy development. We enhance research collaborations by championing grant applications, licensing agreements, and mergers and acquisitions.
What We Do
We have developed a technology portfolio primarily focused on analogs of antimicrobial drug candidates. We expand your team to include drug development experts with deep industry knowledge. We champion fundraising efforts around in-kind investments and non-dilutive government funds. We streamline processes to de-risk your technology with established preclinical development teams: In vitro ADME, In vivo PK/PD, Formulation, Exploratory toxicology, Clinical Strategy, Regulatory strategy, Intellectual property strategy
For more information, contact Business Development at bd@tsrlinc.com
